<DOC>
	<DOCNO>NCT02111629</DOCNO>
	<brief_summary>Genital tract infection ( GTIs ) increase past decade association sexually transmit infection ( STIs ) infection like bacterial vaginosis ( BV ) , HIV transmission . BV Candida common cause vaginal infection symptomatic woman , prevalence BV 22-50 % prevalence Candida 17-39 % . In effort reduce transmission GTIs , World Health Organization ( WHO ) propose syndromic diagnostic approach low cost alternative place access laboratory diagnostic test . Justification . In patient syndrome vaginal discharge , effective treatment Candida albicans , Trichomonas vaginalis , bacterial vaginosis adviced , therefore , syndromic management symptomatic vaginal discharge combination fluconazole secnidazole could use . No study evaluate combination find literature review . Objectives : To describe safety clinical microbiological efficacy single oral dose combine treatment secnidazole + fluconazole syndromic management symptomatic vaginal discharge . Methods : Design : open label , uncontrolled clinical trial estimate clinical efficacy safety combination fluconazole secnidazole treatment symptomatic vaginal discharge . The participant sexually active woman low genital tract symptom ( leukorrhea , itching , burning , pain , foul-smelling vaginal discharge , urethral symptom ) compatible symptomatic vaginal discharge syndrome . The study conduct outpatient service hospital Bogota , Colombia . Given descriptive character study , priori hypothesis consider . A consecutive convenience sample size 100 symptomatic patient calculate . The statistical analysis perform STATA 11.0 software ( College Station , Texas , USA ) . Simple relative frequency measure central tendency dispersion appropriate distribution variable calculate . The study submit approve Ethics Committee Faculty Medicine National University Colombia Institutional Review Board participate institution . All woman must sign write informed consent form agree voluntarily participate study .</brief_summary>
	<brief_title>Safety Clinical Microbiological Efficacy Combination Fluconazole Secnidazole Treatment Symptomatic Vaginal Discharge</brief_title>
	<detailed_description />
	<mesh_term>Vaginal Discharge</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Secnidazole</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>sexually active woman low genital tract symptom compatible BV vaginitis patient clinical diagnosis cervicitis severe medical condition liver disease allergy , know reaction drug study exclude study pregnant woman woman yet sexually active woman previously participate study woman receive antibiotic therapy previous 14 day</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Vaginosis , bacterial ; Candidiasis , vulvovaginal</keyword>
</DOC>